DCM
RMD icon

Davidson Capital Management’s ResMed RMD Stock Holding History

Davidson Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,199
Closed -$1.35M – 98
2021
Q4 		$1.35M Buy
5,199
+278
+6% +$72.1K 0.74% 49
2021
Q3 		$1.3M Sell
4,921
-1,129
-19% -$309K 0.65% 28
2021
Q2 		$1.49M Sell
6,050
-168
-3% -$35.3K 0.72% 11
2021
Q1 		$1.21M Buy
+6,218
New +$1.25M 0.63% 28

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Davidson Capital Management's RMD Position: Q1 2022 in Review

Davidson Capital Management sold out of ResMed (RMD) in Q1 2022, closing a stake of 5,199 shares — an estimated $1.35M sold.

Davidson Capital Management first reported a position in RMD in Q1 2021 and held it in 4 quarters. The position peaked at $1.49M in Q2 2021. 682 funds tracked by Wall St. Rank hold RMD as of Q1 2022.

  • Davidson Capital Management reported no remaining ResMed position as of Q1 2022 after selling out during the quarter.
  • Davidson Capital Management sold 5,199 ResMed shares in Q1 2022, an estimated $1.35M.
  • Davidson Capital Management first reported a position in ResMed in Q1 2021 and held it in 4 quarters.
  • Davidson Capital Management's ResMed position peaked at $1.49M in Q2 2021.
  • 682 funds tracked by Wall St. Rank held ResMed as of Q1 2022.

Based on Davidson Capital Management's 13F filing for Q1 2022, filed 17 May 2022.